
César Serrano García/X
Mar 23, 2025, 07:57
César Serrano García: Neoadjuvant chemotherapy and immunotherapy in sarcomas
César Serrano García, Group Leader of VHIO´s Sarcoma Translational Research Group, shared a post on X:
“Neoadjuvant chemotherapy and immunotherapy in sarcomas.
Select subtypes and stratify:
- Don’t focus only on ICIs – test new agents.
- Include pathological response as an endpoint.
- Use novel trial designs.
Wonderful overview from Maud Toulmonde at ESMO Rare Cancers 2025.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 23, 2025, 07:57
Mar 23, 2025, 07:36
Mar 23, 2025, 07:25
Mar 23, 2025, 06:59
Mar 23, 2025, 06:47
Mar 23, 2025, 06:16
Mar 23, 2025, 05:49